Cart
sales@molnova.com
Olanzapine impurity L HCl
CAS No. 138564-60-0
Olanzapine impurity L HCl( —— )
Catalog No. M35876 CAS No. 138564-60-0
Olanzapine impurity L HCl is an impurity generated during the production of Olanzapine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 48 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 152 | In Stock |
|
| 100MG | 222 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 548 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOlanzapine impurity L HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionOlanzapine impurity L HCl is an impurity generated during the production of Olanzapine.
-
DescriptionOlanzapine impurity L HCl is an impurity generated during the production of Olanzapine.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number138564-60-0
-
Formula Weight265.76
-
Molecular FormulaC12H12ClN3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.N1=C(N)C=2C=C(SC2NC=3C=CC=CC13)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Shield-1
Shield-1 is a specific, high-affinity and cell-permeant ligand of FK506-binding protein-12 (FKBP), and reverses the instability by binding to mutated FKBP (mtFKBP), allowing conditional expression of mtFKBP-fused proteins. Shield-1 can stabilize the entire fusion protein.
-
B I09
B I09, an IRE-1 RNase inhibitor with an IC50 of 1230 nM, inhibits splicing of XBP1 mRNA in human WaC3 cells and expression of xbp-1 in LPS-stimulated B cells. B I09 can be used to simulate the defects of XBP-1 in CLL cells.
-
Thalidomide-NH-C2-PE...
Thalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
